# Debbie Lin

> Debbie Lin is a Series A investor at Boehringer Ingelheim Venture Fund backing Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Boehringer Ingelheim Venture Fund](https://shizune.co/investors/profile/boehringer-ingelheim-venture-fund)
- Location: Cambridge, United States
- Total investments: 1
- Last investment: Oct 2021
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/debbie-w-lin-9209083/

Debbie Lin is a Series A investor at Boehringer Ingelheim Venture Fund in Cambridge focused on Biotechnology and Medical Device. Debbie Lin, Investor and Executive Director at Boehringer Ingelheim Venture Fund.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 1 | 100% |
| Medical Device | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Optina Diagnostics | Optina Diagnostics develops technology for the early detection of disease through the eye. | $20.1M | Series A | Oct 28, 2021 |  |

1 of 1 investments shown.

## Co-investors
- [Advisors.fund](https://shizune.co/investors/profile/advisors-fund) — VC Fund, 1 deal together
- [Biomed Propulsion](https://shizune.co/investors/profile/biomed-propulsion) — VC Fund, 1 deal together
- [Desjardins Venture Capital](https://shizune.co/investors/profile/desjardins-venture-capital) — VC Fund, 1 deal together
- [DigitalDx Ventures](https://shizune.co/investors/profile/digitaldx-ventures) — VC Fund, 1 deal together
- [Hike Ventures](https://shizune.co/investors/profile/hike-ventures) — VC Fund, 1 deal together
- [MEDTEQ+](https://shizune.co/investors/profile/medteq) — VC Fund, 1 deal together

## About Boehringer Ingelheim Venture Fund

VC Fund · Ingelheim Am Rhein, Germany

Boehringer Ingelheim Venture Fund intends to invest in groundbreaking therapeutic approaches and technologies.

4 contacts available at Boehringer Ingelheim Venture Fund.

| Name | Title | Profile |
| --- | --- | --- |
| Debbie Lin | Executive Director | https://shizune.co/investors/profile/debbie-w-lin |
| Knut Elbers | Project Manager | https://shizune.co/investors/profile/knut-elbers |
| Martin Heidecker | Managing Director | https://shizune.co/investors/profile/martin-heidecker |
| Oliver Reuss | Executive Director and Investment Manager | https://shizune.co/investors/profile/oliver-reuss |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Debbie Lin invest in?

Debbie Lin invests primarily in Biotechnology and Medical Device startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Debbie Lin last invest?

The most recent investment recorded for Debbie Lin closed in Oct 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co